###begin article-title 0
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction
###end article-title 0
###begin p 1
Present addresses: Gusztav Belteki, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK
###end p 1
###begin p 2
Jody Haigh and Katharina Haigh, Department for Molecular Biomedical Research, Flanders Interuniversity Institute of Biotechnology (VIB), Ghent University, Technologiepark 927, B-9052 Ghent (Zwijnaarde), Belgium
###end p 2
###begin p 3
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 3
###begin p 4
###xml 606 642 606 642 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oupjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
###end p 4
###begin p 5
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
Here we describe a triple transgenic mouse system, which combines the tissue specificity of any Cre-transgenic line with the inducibility of the reverse tetracycline transactivator (rtTA)/tetracycline-responsive element (tet-O)-driven transgenes. To ensure reliable rtTA expression in a broad range of cell types, we have targeted the rtTA transgene into the ROSA26 locus. The rtTA expression, however, is conditional to a Cre recombinase-mediated excision of a STOP region from the ROSA26 locus. We demonstrate the utility of this technology through the inducible expression of the vascular endothelial growth factor (VEGF-A) during embryonic development and postnatally in adult mice. Our results of adult induction recapitulate several different hepatic and immune cell pathological phenotypes associated with increased systemic VEGF-A protein levels. This system will be useful for studying genes in which temporal control of expression is necessary for the discovery of the full spectrum of functions. The presented approach abrogates the need to generate tissue-specific rtTA transgenes for tissues where well-characterized Cre lines already exist.
###end p 5
###begin title 6
INTRODUCTION
###end title 6
###begin p 7
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
Cellular diversity in a developing organism is achieved by spatial and temporal regulation of gene expression determined by genetic programs and inductive signals. As a consequence, genes have spatially and temporally acting multiple functions, which are difficult to dissect without proper genetic tools providing similar complexity of control of expression-disruption or overexpression of a gene of interest (1,2). Uncontrolled transgenic expression of a given gene in all tissues or even in restricted cell types may be associated with embryonic lethality that precludes further studies at later stages of development or in adults.
###end p 7
###begin p 8
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 925 926 925 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 927 928 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
Cell type-/tissues-specific mutation of a gene can be achieved by a two-step process; introduction of loxP sites around a functionally essential genomic part followed by a cell type-specific Cre recombinase-mediated excision of the loxP flanked sequence. The same strategy can be used for cell type-specific overexpression of a transgene, when a strong overall expressing promoter is separated from the coding region of a gene of interest by loxP flanked 'STOP' sequences (1,3-5). In both scenarios, a Cre recombinase transgene provides spatial control. However, once Cre expression has been switched on and recombination has occurred, the resultant change in gene expression is, in most cases, irreversible. Tetracycline-inducible transgenic systems [tetracycline transactivator (tTA) or 'Tet-Off' and reverse tetracycline transactivator (rtTA) or 'Tet-On'] allow for reversible temporal regulation of transgene expression (6,7). Of the two systems, rtTA is better suited for rapid induction of gene expression.
###end p 8
###begin p 9
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF</italic>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 804 807 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 808 809 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
In the following report, we describe a novel system that allows for the spatial and temporal regulation of transgene expression in vivo by combining any of the existing Cre recombinase transgenic lines with the reverse tTA (rtTA)-tet-O system. We targeted rtTA into the widely expressed ROSA26 locus, in a way where rtTA expression is conditional to a Cre-mediated excision event (8). Furthermore, we demonstrate the tightness and inducibility of this approach by systemic and cell type-specific (neuronal and podocyte) inducible expression of a dosage-sensitive gene, VEGF-A (9). The presented mouse line can be used to achieve spatially and temporally controlled transgene expression in a wide variety of settings simply by crossing to any existing mice carrying cell type-specific Cre recombinase and tet-O-regulatable responder genes.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
DNA constructs
###end title 11
###begin p 12
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 841 850 841 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 878 883 <span type="species:ncbi:10090">mouse</span>
An EcoRI fragment carrying the rtTA coding sequence and an N-terminal nuclear localization signal was excised from the plasmid pSPC-rtTA (10), blunted by Klenow enzyme and inserted into the pCALL2-IRES-EGFP plasmid (a gift from Dr Corrine Lobe) at a blunted XhoI site. The resultant vector (pCALL2-rtTA-IRES-EGFP) was first digested with BglII, filled in by Klenow polymerase and then cut with NotI, and the fragment containing rtTA-IRES-EGFP was isolated. The pBigT vector (11) was digested first with SalI, filled in and subsequently digested with NotI. The above fragment was inserted into this vector resulting in pBigT-rtTA-IRES-EGFP. The whole insert of the latter vector was released by AscI-PacI double digest and inserted into pROSA26-PA vector (11) digested by the same enzymes. The resultant target vector was named pROSA26-rtTA (Figure 1A). Before introduction into mouse embryonic stem (ES) cells, the vector was linearized with XhoI.
###end p 12
###begin p 13
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 55 61 <span type="species:ncbi:10090">murine</span>
The murine podocin promoter was amplified from genomic murine DNA as described previously (12) and cloned upstream of the NLS-Cre transgene (a gift from B. Sauer).
###end p 13
###begin title 14
ES cell manipulation
###end title 14
###begin p 15
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 155 156 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 3 8 <span type="species:ncbi:10090">mouse</span>
R1 mouse ES cells (13) were maintained and manipulated as described elsewhere (14). In brief, 20 mug of linearized target vector was electroporated into 107 cells using 500 muF and 250 V settings on Gene Pulser (Bio-Rad). After 24 h, the cells were selected for neomycin resistance in G418 (170 mug/ml) for 8 days. The resistant colonies were picked, expanded and split in 96-well plates, and the master plates were frozen and stored at -80degreesC until genetic characterization identified the correctly targeted clones. Some of these targeted clones were thawed from the master plates, expanded and subjected to further procedures described below.
###end p 15
###begin p 16
###xml 497 499 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
To activate rtTA expression from the ROSA26 locus, the transfection of the selected targeted clones with the pCAGGS-Cre-PGK-puro vector (a gift from C. Lobe) was performed using Lipofectamine 2000 (Invitrogen). An aliquot of 2 mug circular plasmid was transfected into cells growing in a 35 mm diameter dish. During the transfection, OPTI-MEM medium was used. Puromycin selection (1.25 mug/ml) was applied, and resistant colonies expanded. Green fluorescence was detected as described previously (15).
###end p 16
###begin p 17
The pBI-3 plasmid (a gift from H. Bujard) contains a bi-directional tetracycline-responsive element followed by the lacZ coding sequence. This vector was introduced into ES-cells by lipofection according to the protocol above. After 5 h of transfection, doxycycline (Sigma) was added to the medium in differing concentrations. The day after lipofection, the cells were passaged 1:5 and cultured for a further 1-2 days in the presence of doxycyline (100 ng/ml), and then stained by using X-gal.
###end p 17
###begin title 18
Generation of transgenic animals
###end title 18
###begin p 19
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Chimeric mice were generated by aggregation of targeted ES-cells with eight-cell stage embryos as described previously (16). Germline transmitting chimeric males were crossed with outbred ICR females and the offspring were genotyped by Southern blotting and PCR for the transmission of the transgene.
###end p 19
###begin p 20
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
The Cre-recombinase transgenic founder lines were generated as described previously (17). Regarding the Podocin-Cre transgene four individual founder lines were crossed with the Z/EG reporter strain (15) to determine the degree and timing of Cre-mediated DNA excision in podocytes.
###end p 20
###begin title 21
Genotyping by Southern blotting
###end title 21
###begin p 22
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 513 528 513 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A and B</xref>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 657 662 <span type="species:ncbi:10090">mouse</span>
To detect targeting of the ROSA26 locus, genomic DNA was isolated from the ES cells grown on 96-well plates (18), digested with EcoRV and the fragments separated on 0.7% agarose gel. Southern blotting was performed as described previously (19). Briefly, the DNA was transferred onto a nitrocellulose membrane (Hybond N; Amersham) and hybridized with a probe complementary to a sequence upstream of the 5' homology arm of the vector (external probe) or with a probe complementary to the neo gene (internal probe) (Figure 1A and B). The radioactive signal was detected by phosphorimaging. To detect the mutation in mice, 10 mug genomic DNA was extracted from mouse tail biopsies and analyzed by Southern hybridization as above.
###end p 22
###begin title 23
Genotyping by PCR
###end title 23
###begin p 24
###xml 88 89 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 126 129 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
PCR was performed in 25 mul reaction mixture containing standard PCR buffer, 1.0 mM MgCl2, 200 muM dNTPs, 200 nM primers, 5 U Taq polymerase and 100 ng genomic DNA isolated from mouse ear biopsies. The primers for detection of the targeted ROSA26 allele containing the STOP cassette were as follows: ROSA5, GAGTTCTCTGCTGCCTCCTG; and RTTA3, AAGACCGCGAAGAGTTTGTC. The reaction resulted in a 215 bp band. The wild-type ROSA26 allele was detected by an amplicon of 322 bp using primers ROSA5 and ROSA3: CGAGGCGGATACAAGCAATA. The PCR program was as follows: initial denaturation for 1 min at 94degreesC followed by 35 cycles of 1 min at 94degreesC, 45 s at 62degreesC (knock-in allele) or 64degreesC (wild-type allele) and 1 min at 72degreesC and a final extension of 5 min at 72degreesC. PCR products were detected on 2% agarose gel.
###end p 24
###begin title 25
Histology
###end title 25
###begin p 26
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
The X-gal staining of ES cells was performed as described previously (15). Embryonic and adult tissue samples were dissected and fixed overnight in 4% PFA. The following day, the samples were washed extensively with 1x PBS, dehydrated through graded alcohol washes and embedded in paraffin wax as described previously (20). Sections (7 mum) were deparaffinized and stained with Harris' Hematoxylin and Eosin (Sigma Immunochemicals).
###end p 26
###begin title 27
RESULTS AND DISCUSSION
###end title 27
###begin title 28
Generation of the ROSA26-rtTA knock-in ES cell line
###end title 28
###begin p 29
###xml 205 220 205 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A and B</xref>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1042 1050 1042 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
We inserted an artificial exon between the first and the second exons of the mouse ROSA26 locus by gene-targeting. Of the 140 G418 resistant colonies picked and genotyped, 12 (8%) were correctly targeted (Figure 1A and B). In the artificial exon, a loxP site-flanked selectable marker (neo) precedes two coding sequences separated by an internal ribosomal entry site (IRES). The upstream sequence is coding for rtTA with a nuclear localization signal, and the downstream sequence is coding for enhanced green fluorescent protein (EGFP). Translation of the latter is ensured by the IRES sequence. Before Cre-excision, the three consecutive polyadenylation signals of the selectable marker terminate mRNA synthesis and, therefore, the downstream coding sequences are not expressed (8). After Cre-mediated deletion of the loxP flanked sequence, however, rtTA and EGFP are expressed by the ROSA26 promoter. Presence of doxycycline results in the formation of an active transcriptional activator and the activation of the responder transgene (see Figure 2).
###end p 29
###begin title 30
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Assessment of tetracycline-inducibility in vitro
###end title 30
###begin p 31
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 390 399 390 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C</xref>
###xml 680 683 680 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 831 840 831 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1D</xref>
###xml 939 948 939 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1E</xref>
To test the inducibility of the system in vitro, we removed the loxP flanked sequence by transfecting 10 targeted ES cell lines with a plasmid expressing Cre recombinase as well as puromycin acyltransferase (pCAGGS-Cre-PGK-Puro). We isolated stable integrants using puromycin selection and verified that they displayed green fluorescence while the parental cell lines were not fluorescent (Figure 1C and data not shown). There was no difference among the different targeted cell lines. Next, we expanded the fluorescent Cre-excised subclones of two original lines (1C12 and 1H6) and transfected them with a vector containing a lacZ transgene driven by a rtTA-responsive promoter (tet-O-LacZ). (We did not use any selection for transfectants in this experiment.) We did not observe any X-gal activity in the absence of the inducer (Figure 1D). When the medium was supplemented with 100 ng/ml doxycycline, LacZ positive cells were detected (Figure 1E).
###end p 31
###begin title 32
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Inducible overexpression of VEGF-A in vivo
###end title 32
###begin p 33
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
Two ES-cell clones were used to generate chimeric mice by ES cells <--> embryo aggregation. In both experiments, germline transmission was obtained. Heterozygous animals of both lines were healthy, fertile and had a normal lifespan. Heterozygotes from one of the lines (1C12) were intercrossed, resulting in litters of pups with a Mendelian distribution of the F2 genotypes. Homozygous transgenic animals were healthy and fertile and were used to maintain this line in the homozygous state. These homozygous, Cre-conditional ROSA26-rtTA mice were used in consecutive experiments.
###end p 33
###begin p 34
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 274 277 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 370 374 370 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 420 424 420 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 466 470 466 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 482 490 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
In order to test the in vivo 'silent but inducible' nature of the conditional ROSA26-rtTA-IRES-EGFP transgene and rtTA protein activity, male mice that were homozygous for the Cre-conditional ROSA26-rtTA allele were bred with female mice that were double heterozygous for a tet-O-VEGF-A-164 responder transgene (21) and either the ubiquitous Cre-deletor line (pCAGGS-CreTg/+) (5) or a nervous system specific (Nestin-CreTg/+) (22) or a podocyte specific (Podocin-CreTg/+) Cre line. Figure 2 describes how the three transgenes work to unite the Cre/loxP and tetracycline inducible systems.
###end p 34
###begin p 35
###xml 166 181 166 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B and E</xref>
###xml 379 388 379 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3G</xref>
###xml 434 443 434 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3J</xref>
Since the pCAGGS-Cre transgene expresses Cre in all the cells of the early embryo, it activates an overall rtTA and EGFP expression as shown for a E9.5 day embryo in Figure 3B and E. On the other hand, breeding with the Nestin-Cre or Podocin-Cre line resulted in embryos/animals with neuronal lineage or glomerulus-specific expression of rtTA and EGFP, respectively, as shown in Figure 3G for a E10.5 day embryo for Nestin-Cre and in Figure 3J for a newborn glomerulus for Podocin-Cre. In the absence of Cre-mediated excision of the loxP-flanked PGK-neo-pA sequence blocks rtTA and EGFP expression.
###end p 35
###begin p 36
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 275 279 275 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 302 306 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 324 328 324 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 338 353 338 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A and B</xref>
###xml 572 587 572 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3D and E</xref>
###xml 596 603 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 749 758 749 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3D</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1111 1120 1111 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3F</xref>
###xml 1290 1299 1290 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 1378 1387 1378 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3F</xref>
###xml 1526 1533 1526 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1689 1693 1689 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1695 1698 1695 1698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 1699 1700 1699 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1711 1715 1711 1715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 2036 2038 2036 2038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
We made use of the tight dosage sensitivity of the early developing embryo to increased (9,23) or decreased levels of VEGF-A (20,23-26) to demonstrate the correct activation of our inducible system. In the absence of the rtTA-inducer doxycycline, triple transgenic pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ embryos (Figure 3A and B) develop normally and show no phenotype. However, in the presence of doxycycline that was administered to pregnant females starting one day after mating (E1.5), all of these triple transgenic embryos showed lethality (Figure 3D and E and see Table 1) at E9.5. The phenotypes of these mutant embryos were quite severe with no primitive red blood cells (RBCs) observed in the developing yolk sac (Figure 3D) and embryos were blocked in development. Unlike the original homozygous VEGF-A mutants that showed a severe reduction of blood island development in the yolk sac (24,25), ubiquitous VEGF-A-164 expression in this triple transgenic inducible system led to enlarged blood islands in the yolk sac that were filled with nucleated erythroblast progenitors (Figure 3F). The normal blood islands that developed in the non-induced embryos showed clearly defined endodermal and mesodermal layers 'sandwiching' the developing blood islands (Figure 3C); however, in the doxycycline-induced embryos, aberrant blood islands formed (Figure 3F). All the 10 triple transgenic embryos showed the same mutant phenotype described above upon doxycycline administration to their mothers (Table 1). Out of the 22 remaining littermates that were either single or double transgenic for the three transgenes, 20 appeared totally normal. Two rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+, Cre-negative embryos (as judged by Southern hybridization and PCR, data not shown), however, were also EGFP expressers indicating that rtTA expression activation (Cre-excision) occurred by maternally produced Cre protein. This known phenomenon is a consequence of high-Cre production and accumulation during oogenesis (27).
###end p 36
###begin p 37
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 411 430 411 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bartonella henselae</italic>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 687 691 687 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 714 718 714 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 724 725 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 736 740 736 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 836 843 836 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 969 988 969 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A&#8211;C and G&#8211;I</xref>
###xml 1095 1099 1095 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1122 1126 1122 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1128 1131 1128 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 1132 1133 1132 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1144 1148 1144 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1953 1957 1953 1957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1959 1962 1959 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 1963 1964 1963 1964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1975 1979 1975 1979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 2163 2165 2163 2165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 411 430 <span type="species:ncbi:38323">Bartonella henselae</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 859 874 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
###xml 1381 1396 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1560 1564 <span type="species:ncbi:10090">mice</span>
###xml 2000 2005 <span type="species:ncbi:10090">mouse</span>
###xml 2051 2056 <span type="species:ncbi:10090">mouse</span>
The ubiquitous systemic administration or induction of the VEGF-A-164 protein, or injection of tumor cells expressing high levels of VEGF-A-164 protein into adult mice, results in severe edema (28-30), defects in immune cell function including destruction of the thymus (31-33) and liver pathologies that closely resemble the human syndrome known as peliosis hepatis that has been described in association with Bartonella henselae infection, long-term high-dose androgen therapy, or rarely with advanced cancers (34). In order to determine if doxycycline-induced overall VEGF-A-164 expression could mimic some or all of these previously described phenotypes, triple transgenic pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ mice were allowed to reach adulthood and a regimen of doxycycline administration was followed (Table 1). These triple transgenic mice were born in a normal Mendelian frequency and showed no sign of any phenotypic abnormalities (Figure 4A-C and G-I, and data not shown). Upon administration of doxycycline in the drinking water to 3-4 month old pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ mice, several phenotypes became apparent already after 2 days of treatment. The mice showed signs of edema and erythema of the face, ears and feet (data not shown). By 5 days of doxycycline administration, three of the eight triple transgenic mice had died and three were so moribund and sickly in appearance that they had to be euthanized and their organs were harvested for further histological analysis. Two mice seemed more resistant to the doxycycline administration and were given the drug for an additional 4 days at which time they too became moribund and were as well sacrificed. Of the 10 single and double transgenic littermates, 9 were completely normal and showed no adverse side affects to the doxycycline administration. Similar to what was observed in the E9.5 embryos, one rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+, Cre-negative adult mouse died during doxycycline administration. This mouse, however, was EGFP positive, indicating the rtTA expression activation by zygotic (maternal) Cre protein (27). Upon autopsy, the most obvious gross phenotypes observed were an extended blood filled liver and a dramatic decrease in the size of the thymus together with enlarged lymph nodes and signs of hyper-vascularity/permeability and edema in several other organ systems as well as blood in the intestine (data not shown).
###end p 37
###begin p 38
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 85 89 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 107 111 107 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 171 182 171 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A&#8211;C</xref>
###xml 222 226 222 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 271 275 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 334 343 334 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D</xref>
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4E</xref>
###xml 557 568 557 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D&#8211;F</xref>
###xml 680 689 680 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4F</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 921 926 921 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1372 1374 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1465 1467 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
Histological analysis of the liver of uninduced pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ adult mice (control) revealed normal hepatic architecture (Figure 4A-C). Doxycycline-treated mutant pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ adult livers showed a dramatic 'peliosis-like' phenotype (Figure 4D) and signs of blood pooling in large areas of the liver (arrows in Figure 4E). This liver peliosis phenotype is characterized by enlarged hepatic sinusoids and a total disruption of the normal liver architecture (Figure 4D-F) as well as detached sinusoidal endothelial cells that are 'sloughing-off' into the sinusoidal space (arrow in Figure 4F). The liver pathology described here resembles the liver peliosis-like pathology recently described in mice that had been engrafted with tumor cells expressing high levels of systemic VEGF-A-164 protein (34). In addition, LeCouter et al. (35) have observed similar (although less severe) liver enlargement phenotypes and effects on the sinusoidal endothelium of the liver with systemic administration of recombinant VEGF-A protein. It was also demonstrated that VEGF-A at lower doses can act on the sinusoidal vasculature (via Flt1) to influence secretion of hepatocyte growth factor (HGF) and may have a beneficial protective effect on hepatocytes under times of cytotoxic stress (35). Our VEGF-A inducible system with liver-specific Cre lines such as the albumin-Cre line (36) will be useful in determining the optimal dosages of VEGF-A required for its beneficial action on the liver under times of cytotoxic stress and may at higher induction levels be a useful model system to unravel the molecular mechanisms behind VEGF-A's harmful effects on the liver.
###end p 38
###begin p 39
###xml 36 40 36 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 85 89 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 260 271 260 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4G&#8211;I</xref>
###xml 336 337 336 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 357 358 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 371 372 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 501 508 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 595 606 595 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4J&#8211;L</xref>
###xml 806 815 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4L</xref>
###xml 881 882 881 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 901 902 901 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 912 913 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 927 928 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1176 1177 1176 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1336 1347 1336 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4J&#8211;L</xref>
###xml 1504 1506 1504 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 2099 2101 2099 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 2102 2104 2102 2104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
The thymus of non-induced pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ adult mice (control) displayed a normal thymic architecture with a well-defined cortical layer rich in basophilic thymocytes and a normal epitheloid-rich medullary zone (Figure 4G-I). Total average cell counts for two control thymi were 1.33 x 108 cells/ml (1.05 x 108 and 1.6 x 108 cells/ml in the two different controls). Representative histological analysis of the thymi of VEGF-A-164-induced mutant adults (Table 1) revealed a dramatic decrease in cellularity that correlated with its decreased size (Figure 4J-L). The mutant thymi lacked major histological distinctions between the medullary and cortical layers and the basophilic cortical layer that is usually rich in thymocytes was almost completely absent (Figure 4L). Total average cell counts for three mutant thymi were 1.37 x 107 cells/ml (3.9 x 107, 8.1 x 105 and 1.14 x 106 cells/ml per animal). These numbers may under-represent the acellularity of the mutant thymi as two of the higher values were from the two animals that survived the initial five-day period of doxycycline treatment. The lower cell count of 8.1 x 105 cells/ml from one of the original sick animals that had to be euthanized in the first five-day period may be more representative of the acellularity shown in Figure 4J-L. The thymic atrophy presented in this paper phenocopies previous reports concerning the detrimental effects that systemic VEGF-A has on T-cell development (33). In addition, ubiquitous expression of VEGF-A-164 during early development seems to give rise to increased numbers of erythroblasts and may inhibit the differentiation of these progenitors. From this study, it is not clear whether this phenotype is caused by alterations in the yolk sac environment or by artificial VEGF-A-164 autocrine loop created. We are currently investigating the molecular mechanisms behind VEGF-A's suppressive effects on different hematopoietic populations through the use of this transgenic system together with additional hematopoietic lineage-specific Cre lines (37,38).
###end p 39
###begin p 40
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 324 328 324 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 351 355 351 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 373 377 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 590 605 590 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3H and I</xref>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 948 953 <span type="species:ncbi:10090">mouse</span>
The developing nervous system is also sensitive to altered VEGF-A expression, We have recently demonstrated that downregulation of the level of this growth factor, using a Nestin-Cre transgene and a conditional targeted allele of VEGF-A, have severe consequences to cortical vessel density and structure (39). The Nestin-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ triple transgenic embryos presented here developed vascular abnormalities by E12.5, associated with spinal cord and brain hemorrhages, when doxycycline was administered to their mother from 1.5 dpc of pregnancy (Figure 3H and I). Without doxycycline administration to the mother, these embryos developed normally and reached adulthood. Interestingly, when these mice received doxycycline for 5 days at 4 months of age, they did not show any obvious gross behavioral or phenotypic abnormalities. Initial vessel and histological analysis from two of the six treated adult mouse brains did not reveal any striking differences in vessel architecture or structural organization of the cortex (data not shown). This result may indicate an increased resistance of the adult CNS vasculature to VEGF-A. We are currently further examining the potential effects of doxycycline-induced increases of VEGF-A-164 and its effects on the developing and adult nervous system using this triple transgenic system.
###end p 40
###begin p 41
###xml 28 32 28 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 55 59 55 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 89 104 <span type="species:ncbi:10090">transgenic mice</span>
###xml 640 648 <span type="species:ncbi:9606">patients</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
In contrast, the Podocin-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ triple transgenic mice treated with doxycycline for 7 days starting at 4 months of age developed proteinuria (albumin >5 g/l, data not shown). The presence of albuminuria in concentrations >3 g/l is designated 'nephrotic range proteinuria'. This degree of proteinuria represents loss of the permeselective function of the glomerular filtration barrier. Increased permeability in the glomerulus leads to the loss of critical blood proteins, including albumin, blood clotting factor inhibitors and lipids, and is associated with edema and thrombotic events in patients. These mice are currently under detailed phenotypic analysis to identify the nature of changes in the kidney caused by induction VEGF-A expression in podocytes.
###end p 41
###begin p 42
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1358 1361 1358 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 1362 1363 1362 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
###xml 759 764 <span type="species:ncbi:10090">mouse</span>
Table 1 displays the results of all the experiments described above. In summary, by combining existing tissue-specific Cre-transgenic mouse strains to define spatial, and the tetracycline-inducible system to define temporal aspect of transgene expression, we have developed a versatile system which allows quick and efficient investigation of multiple gene functions. This aim has also been addressed by others using hormone-activated Cre proteins (40,41). The major advantage of these earlier efforts lie in that only two transgenes have to be combined. However, our system allows for complete on/off control of expression. In addition, the existing inducible systems cannot be combined with and take advantage of the large number of existing Cre-transgenic mouse strains defining tissue/cell type-specificities. Our results show that when expressed from the ROSA26 locus, the baseline activity of rtTA in the absence of inducer is not sufficient to cause significant activation of a responsive promoter. This is in agreement with the findings of Wutz and Jaenisch (42), who used constitutive rtTA expression from the ROSA26 promoter. We expect though that the ROSA26 locus placed rtTA could be a limitation by providing only a given level of expression for rtTA, which might not be high enough to reach sufficient level of induction of different responder tet-O-genes in certain anatomical areas or cell types. Therefore, an obvious future improvement of the presented system would be the establishment of Cre conditional rtTA transgenes in several genomic positions permissive to different level of overall expression. Our ROSA26 placed Cre-conditional system could be the first member of this envisioned useful series.
###end p 42
###begin p 43
We are grateful to Dr C. G. Lobe for providing the pCALL2-IRES-EGFP and to Dr H. Bujard for the pBI-3 vectors. These studies were supported in part by a National Cancer Institute of Canada grant (NCIC grant 21335). J.H. was a recipient of an NCIC postdoctoral fellowship. A.N. is a senior Canadian Institutes of Health Research (CIHR) scientist. S.E.Q. is supported by CIHR grant no. 62931. Funding to pay the Open Access publication charges for this article was provided by NCIC 021335.
###end p 43
###begin p 44
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 44
###begin title 45
REFERENCES
###end title 45
###begin article-title 46
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Conditional control of gene expression in the mouse
###end article-title 46
###begin article-title 47
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Conditional genome alteration in mice
###end article-title 47
###begin article-title 48
###xml 47 62 <span type="species:ncbi:10090">transgenic mice</span>
Tissue- and site-specific DNA recombination in transgenic mice
###end article-title 48
###begin article-title 49
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
Targeted oncogene activation by site-specific recombination in transgenic mice
###end article-title 49
###begin article-title 50
Cre recombinase: the universal reagent for genome tailoring
###end article-title 50
###begin article-title 51
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
###end article-title 51
###begin article-title 52
Transcriptional activation by tetracyclines in mammalian cells
###end article-title 52
###begin article-title 53
Generalized lacZ expression with the ROSA26 Cre reporter strain
###end article-title 53
###begin article-title 54
Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression
###end article-title 54
###begin article-title 55
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Conditional gene expression in the respiratory epithelium of the mouse
###end article-title 55
###begin article-title 56
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
###end article-title 56
###begin article-title 57
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
Two gene fragments that direct podocyte-specific expression in transgenic mice
###end article-title 57
###begin article-title 58
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells
###end article-title 58
###begin article-title 59
ES cell-mediated conditional transgenesis
###end article-title 59
###begin article-title 60
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision
###end article-title 60
###begin article-title 61
Production and analysis of ES cell aggregation chimeras
###end article-title 61
###begin article-title 62
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Glomerular-specific gene excision in vivo
###end article-title 62
###begin article-title 63
Genomic DNA microextraction: a method to screen numerous samples
###end article-title 63
###begin article-title 64
Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state
###end article-title 64
###begin article-title 65
###xml 87 91 <span type="species:ncbi:10090">mice</span>
VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice
###end article-title 65
###begin article-title 66
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
###end article-title 66
###begin article-title 67
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
###end article-title 67
###begin article-title 68
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
###end article-title 68
###begin article-title 69
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
###end article-title 69
###begin article-title 70
Insufficient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation
###end article-title 70
###begin article-title 71
Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase
###end article-title 71
###begin article-title 72
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
###end article-title 72
###begin article-title 73
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
###end article-title 73
###begin article-title 74
Induction of vascular networks in adult organs: implications to proangiogenic therapy
###end article-title 74
###begin article-title 75
###xml 52 57 <span type="species:ncbi:9606">human</span>
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
###end article-title 75
###begin article-title 76
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
###end article-title 76
###begin article-title 77
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression
###end article-title 77
###begin article-title 78
Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome
###end article-title 78
###begin article-title 79
Angiogenesis-independent endothelial protection of liver: role of VEGFR-1
###end article-title 79
###begin article-title 80
DNA excision in liver by an albumin-Cre transgene occurs progressively with age
###end article-title 80
###begin article-title 81
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for visualization and conditional mutations in the erythroid lineage
###end article-title 81
###begin article-title 82
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice with hematopoietic and lymphoid specific expression of Cre
###end article-title 82
###begin article-title 83
Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling
###end article-title 83
###begin article-title 84
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Ligand-activated site-specific recombination in mice
###end article-title 84
###begin article-title 85
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Inducible site-directed recombination in mouse embryonic stem cells
###end article-title 85
###begin article-title 86
A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation
###end article-title 86
###begin title 87
Figures and Tables
###end title 87
###begin p 88
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROSA26</italic>
###xml 373 374 373 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 497 500 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 516 517 516 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 695 696 695 696 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 701 702 701 702 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 816 819 816 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 820 821 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 822 826 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
Targeted insertion of a conditional rtTA-IRES-EGFP transgene into the ROSA26 locus. (A) Targeting strategy. The exons of the ROSA26 gene are depicted as numbered boxes, and the triangles as loxP sites. The insertion point (XbaI site), informative restriction sites and diagnostic fragments are also shown. Abbreviations are explained in the text. Drawing is not to scale. (B) Southern-blot analysis of genomic DNA from ES cells digested by EcoRV and hybridized with a 5' external probe (left) and neo probe (right) (C) After Cre-excision, cells show green fluroescence. Line 1C12 was transfected with a plasmid carrying Cre and puro expression cassettes. A puromycin-resistant colony is shown. (D and E) Tetracyclin-induction of lacZ in Cre-excised 1C12 cells. The cells were transfected with a plasmid containing a tet-O-lacZ transgene. (D) No doxycycline induction. (E) Cells after doxycycline administration (100 ng/ml for 2 days).
###end p 88
###begin p 89
###xml 80 81 80 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 327 330 327 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 423 427 423 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 455 459 455 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 471 475 471 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 479 480 479 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 598 599 598 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 766 769 766 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 770 771 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 83 87 <span type="species:ncbi:10090">Mice</span>
###xml 225 240 <span type="species:ncbi:10090">transgenic mice</span>
Operation of the Cre/loxP-dependent, tetracycline inducible transgenic system. (A) Mice that are homozygous for the targeted insertion of the conditional rtTA-IRES-EGFP bicistronic transgene at ROSA26 can be bred with double transgenic mice that carry a tissue-specific Cre transgene and a doxycycline-inducible rtTA-dependent tet-O-GENE responder line. A total of 25% of the pups will be triple transgenic (SpecPromoterCreTg/+, ROSA26-STOP-rtTA-IRES-EGFPTg/+, tet-O-GENETg/+). (B) In cells that do not express Cre, neither rtTA nor EGFP protein is generated; therefore, the tet-O-GENE is silent. (C) In Cre-expressing cells, rtTA and EGFP expression is turned on. However, in the absence of an inducer (e.g. doxycycline), rtTA cannot activate the expression of the tet-O-GENE target. Addition of doxycycline results in the formation of an active transactivator and expression of the target gene. In the present study, VEGF-A-164 was induced either ubiquitously or nervous system or podocyte specifically in the presence of doxycycline.
###end p 89
###begin p 90
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 176 177 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 178 179 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 219 223 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 246 250 246 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 252 255 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 268 272 268 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 735 736 735 736 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 737 738 737 738 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1369 1370 1369 1370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1406 1410 1406 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1433 1437 1433 1437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1439 1444 1439 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet-O</italic>
###xml 1455 1459 1455 1459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 1574 1575 1574 1575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1580 1581 1580 1581 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 1808 1809 1808 1809 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
Tissue-specific expression of the rtTA-IRES-EGFP bicistronic transgene is Cre-dependent and the rtTA trans-activation of tet-O-VEGF-A-164 is tightly regulated by doxycycline. (A-C) Images of triple transgenic pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ E9.5 embryo and yolk sac in the absence of doxycycline: (A), Whole mount bright field microscopy; (B), GFP fluorescence microscopy; and (C), H&E histological section of the yolk sac. In the absence of doxycycline, triple transgenic embryos develop normally. Arrow in (A) shows normal yolk sac vessel with primitive hemoglobin-containing RBCs and normal blood island (BI) formation between the primitive endoderm (e) and mesoderm (m) layers of the yolk sac (C). (D-F) Triple transgenic embryo and yolk sac, the mother treated with doxycycline. (D), Whole mount bright field microscopy; (E), GFP fluorescence microscopy; and (F), H&E histological section of the yolk sac. (D) In the presence of doxycycline the triple transgenic embryos show a lethal phenotype with no proper vessel development in the yolk sac (ys) and embryo (e), no hemoglobin-containing RBC (D) and abnormal blood island (BI) structures that are filled with excessive nucleated erythroblasts (EB). (B and E) The overall EGFP signal marks the overall rtTA expression in the yolk sac and embryo of the triple transgenic embryos. (G) E10.5 triple transgenic Nestin-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ embryos develop normally in the absence of doxycycline and show nervous system specific expression of EGFP/rtTA. (H and I) E12.5 triple transgenic embryos when the mother was either non-treated (H) or treated (I) with doxycycline during the pregnancy. The VEGF-A-164 induced embryo (I) shows hemorrhages in the developing nervous system (arrows). (J) Immunostaining for EGFP shows the podocyte specificity of Podocin-Cre excision.
###end p 90
###begin p 91
###xml 147 151 147 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 174 178 174 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tet</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 196 200 196 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tg/+</sup>
###xml 279 280 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 281 282 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 320 321 320 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 322 323 322 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 832 833 832 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 834 835 834 835 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 902 903 902 903 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J</bold>
###xml 904 905 904 905 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
Liver peliosis-like phenotype and thymus degeneration are associated with the doxycycline-induced overall VEGF-A-164 expression in adult pCAGGS-CreTg/+, ROSA26-rtTA-IRES-EGFPTg/+, tet-O-VEGF-A-164Tg/+ mice. H&E histological analysis of livers of triple transgenic adult mice of (A-C): VEGF-A-164 non-induced (-DOX) and (D-F): VEGF-A-164 induced (+DOX) by doxycycline treatment. Without doxycyclin treatment, livers have a normal hepatic architecture with well-defined vasculature and normal hepatic venules (V) and hepatic sinusoids (HS) (C). The doxycycline-treated mutant livers show major disruptions of normal hepatic architecture with a severe dilation of hepatic sinusoids (HS) (F) and evidence of blood engorgement and pooling [arrows in (E)]. Arrow in (F) shows evidence of sinusoidal endothelial sloughing and detachment. (G-I): H&E histological analysis of VEGF-A-164 non-induced (-DOX) and (J-L): VEGF-A-164 induced (+DOX) thymus of triple transgenic adult mice. Without doxycycline treatment the thymus shows normal thymic architecture with a well-defined cortex layer (cx) that is packed with basophilic lymphocytes and a normal medullary layer (m) that contains fewer lymphocytes but an extensive epithelial framework. Doxycycline-treated mutant thymus shows massive degeneration with all three thymic lobes fitting into a single optical field (J) compared with one thymic lobe fitting into the optic field at the same magnification (G) from control mice. In addition, the mutant thymus lacks a well-defined cortical layer owing to a dramatically decreased number of basophilic thymocytes seen at higher magnifications (L) compared with (I). (A, D, G and J), 50x magnification; (B and E), 125x magnification; (H and K), 250x magnification; and (C, F, I and L), 500x magnification.
###end p 91
###begin p 92
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Summary of doxycycline induction experiments during development and in adult mice
###end p 92

